Comparison of allergen immunotherapy practice patterns in the United States and Europe.
about
Sublingual immunotherapy for asthmaSublingual immunotherapy for asthmaSublingual Immunotherapy: A Useful Tool for the Allergist in Private PracticeT Cell Epitope Peptide Therapy for Allergic DiseasesManagement of the polyallergic patient with allergy immunotherapy: a practice-based approachClinical practice. Allergic rhinitisTherapeutic interventions in severe asthmaRisk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementTypes of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory diseaseIn vitro evaluation of allergen potencies of commercial house dust mite sublingual immunotherapy reagentsOral mucosal immunotherapy for allergic rhinitis: A pilot studyRegulatory aspects of allergen-specific immunotherapy: europe sets the scene for a global approach.Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy ProductsA WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics.Environmental assessment and exposure control of dust mites: a practice parameter.Specific immunotherapy in asthma: efficacy and safety.Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.New directions in immunotherapy.Subcutaneous immunotherapy for allergic rhinitis: an evidence based review of the recent literature with recommendations.Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic reviewSpecific immunotherapy in asthma: a comprehensive review.Arguing the misconceptions in allergen-specific immunotherapy.Progress in the development of specific immunotherapies for house dust mite allergies.Modified allergens and their potential to treat allergic disease.Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.Current developments for improving efficacy of allergy vaccines.Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations.Control Process for Manufacturing and Standardization of Allergenic Molecules.From IgE to clinical trials of allergic rhinitis.Allergen extracts for immunotherapy: to mix or not to mix?Novel strategies for the treatment of grass pollen-induced allergic rhinitis.Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.Allergen immunotherapy in asthma; what is new?Investigational new drugs for allergic rhinitis.European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis.Allergen immunotherapy on the way to product-based evaluation-a WAO statement.Immunotherapy of house dust mite allergy.Sublingual immunotherapy improves symptoms of allergical rhinoconjunctivitis and asthma.
P2860
Q24187736-7BB70C86-1BB1-4996-96C9-F18DF34A6CA1Q24194130-9BB49CF6-B8FF-4921-AF61-5413BDC1AC17Q26747200-40DB01D1-5159-4494-8829-782A5E9CF834Q26771989-8D74CA15-8A27-4247-8C70-4B61A87979DDQ26772200-BE0D51BE-4F3D-43E6-894D-3E7841EAEEBEQ26822043-04C42A2F-75DD-45ED-8EF1-0B08971F6E01Q28079238-B9779DE3-6632-49FE-AB76-55EA835BEE5CQ30371972-80A60070-69D2-490E-8A23-E53C2FD52023Q33592972-903BEC54-015E-44C6-AF6D-A1AEC7B4F47DQ35123904-0387732A-5F09-411D-A4A2-B0D592E80436Q36814140-2A70F686-0D24-4FDE-83B0-78F931522FEDQ36834860-D5052F23-4A6B-4204-8BD7-0E17ACDA39BBQ37231886-0AEB5A29-EC19-486D-A3DF-E5E8F3EC922AQ37418202-986BB578-B44B-4360-8BF9-86008C4A99C8Q37503322-2F983CE4-305F-485F-8814-13A1412F9805Q37831393-B26FEA1E-8086-47DE-B0F1-7839C9FB0B07Q38025664-6462540E-A534-4344-9ADD-67DA6436D9A3Q38073718-6CBABCA2-BE7F-47C1-B8D5-89ABA698E113Q38073749-3C2A944C-B9E4-42D5-91CE-47E7D23FC993Q38104712-D0DE775A-F337-47BE-AA51-829CAA88FC7CQ38161996-2920833C-C239-4E30-A54D-460B85BFA89FQ38217592-F4B97E3B-97C2-42EE-B8A4-45E090AEEAF8Q38245974-18756961-6A8D-4B1C-A89C-CEA0003CCC45Q38255585-8CB1D6FE-8CE6-4DC0-97AF-703BF3D60551Q38262168-415A04B1-4132-4489-AD81-6452E7140914Q38503330-7C022825-F632-4AD6-ADD2-966749AC0EECQ38533962-2A2061FF-0452-4AF9-B74C-F2A89EB8885EQ38542843-B1B6B3D0-DBFD-4A0D-97EB-34547933E9BDQ38584348-C644D594-9BAA-474F-947F-EBD6252E3782Q38664847-99C010D4-E7C7-4DDA-807A-54905035D37FQ38857421-E54E0681-202C-478D-BEB1-5AFA5ECFE598Q38968310-09DF13E0-C9D8-42B9-8BE0-3E3CD84517B6Q39037216-2CA468DC-D7A6-4DB7-8B00-00D814F07235Q39038000-FF1F1563-3C2A-41E1-81B2-49E8EEE3485FQ39111947-32C92BC2-E658-4A25-AC73-735FB15CE49BQ39310240-6C0AF72E-6BCD-4535-8A22-D0DC8B0B8B36Q42428008-805EDD53-FEAE-47D7-9F9B-AB985E93CEF2Q43249691-C78B9954-BCD3-4A53-8B75-C66231F3A681Q43915564-B2277CD9-7433-4322-83FC-DF5903E7C25DQ44543296-1F94F915-CDB3-45B8-AEAC-17FEDCD557F8
P2860
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@en
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@nl
type
label
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@en
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@nl
prefLabel
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@en
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@nl
P1476
Comparison of allergen immunotherapy practice patterns in the United States and Europe.
@en
P2093
Lars Jacobsen
P304
451-59; quiz 459-61, 495
P356
10.1016/S1081-1206(10)60259-1
P577
2009-12-01T00:00:00Z